NCT01446419View on ClinicalTrials.gov

SMART Clinical Study: Surgical Multi-center Assessment of RF Ablation for the Treatment of Vertebrogenic Back Pain

NACompletedINTERVENTIONAL
Enrollment

225

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

March 31, 2015

Study Completion Date

March 31, 2016

Conditions
Low Back Pain
Interventions
DEVICE

Intracept Treatment

Percutaneous transpedicular RF ablation of an intraosseous nerve within the lumbar vertebral body to treat chronic axial low back.

DEVICE

Sham Treatment

Percutaneous transpedicular access to the lumbar vertebra, no RF ablation delivered.

Trial Locations (13)

19107

Rothman Institute, Philadelphia

23235

Virginia iSpine Physicians, Richmond

28207

OrthoCarolina, Charlotte

30060

Pain Center Solutions, Marietta

46032

Indiana Spine Group, Carmel

48033

Partners in Research and Educational Studies of Spinal Disorders (PressD), Southfield

78731

Seton Spine & Scoliosis Center, Austin

85020

Desert Institute for Spine Care, Phoenix

90403

The Spine Institute, Santa Monica

90806

Memorial Orthopedic Surgical Group, Long Beach

94015

SpineCare Medical Group, Daly City

97401

NeuroSpine Institute, Eugene

04074

Maine Medical Partners, Scarborough

All Listed Sponsors
lead

Relievant Medsystems, Inc.

INDUSTRY

NCT01446419 - SMART Clinical Study: Surgical Multi-center Assessment of RF Ablation for the Treatment of Vertebrogenic Back Pain | Biotech Hunter | Biotech Hunter